Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Morgan Stanley

Inception Portfolio Class L (MSSLX)

Ticker MSSLX · · Holdings as of Jun 30, 2026

Expense ratio
1.85%$185/yr per $10k
5-yr return
−5.4%annualized
1-yr return
+0.2%as of Dec 2025
Net assets
$282.2Mall share classes
Holdings
70

Bottom line

Is MSSLX a good fund? The bottom line

MSSLX is the Class L share class of Inception Portfolio, an actively managed large blend mutual fund from Morgan Stanley.

It charges 1.85% — about $185 a year on every $10,000 invested, more expensive than 91% of large blend funds we track.

It returned +0.2% over one year, −5.4% a year over five years, +11.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $282 million in net assets and 70 holdings, its largest position is agilon health Inc (9.1%) and the top 10 make up 55.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.85%)
  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 55.5% of assets
  • 12b-1 marketing fee of 0.75% a year

Updated Nov 19, 2026

What MSSLX invests in

The Inception Portfolio (the Fund) seeks long-term capital appreciation by investing primarily in growth-oriented equity securities of small capitalization companies.

Under normal market conditions, the Adviser seeks to achieve the Funds investment objective by investing primarily in established and emerging companies with capitalizations within the range of companies included in the Russell 2000 Growth Index. As of December 31, 2025 , these market capitalizations ranged between $ 13.7 million and $ 26.0 billion. The Adviser emphasizes a bottom-up stock selection process, seeking attractive investments on an individual company basis. In selecting securities for investment, the Adviser typically invests in unique companies it believes have sustainable competitive advantages with above average business visibility, the ability to deploy capital at high rates of return, strong balance sheets and an attractive risk/reward. The Adviser typically focuses a significant portion of the Funds investments in a limited number of issuers, which may be in the same…

From the fund's prospectus (filed Apr 30, 2026).

MSSLX performance

Average annual total returns
1 yr5 yr10 yr
MSSLX+0.2%−5.4%+11.8%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MSSLX performance history →

What MSSLX costs

On a $10,000 investment, MSSLX's 1.85% expense ratio costs about $185 a year. The prospectus estimates $2,759 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full MSSLX fee table →

MSSLX top 10 holdings

#Holding% of fund
1agilon health Inc9.10%
2Cloudflare Inc8.95%
3Opendoor Technologies Inc7.38%
4Aurora Innovation Inc6.57%
5IonQ Inc5.88%
6X4 Pharmaceuticals Inc3.82%
7HealthEquity Inc3.61%
8Celsius Holdings Inc3.53%
9Immunovant Inc3.44%
10GRAIL Inc3.19%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 55.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSSLX

More funds like MSSLX →

MSSLX FAQ

What is the expense ratio of MSSLX?
MSSLX's expense ratio is 1.85%, which works out to about $185 a year for every $10,000 invested. The prospectus estimates total costs of $2,759 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSSLX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.85%); 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 55.5% of assets; 12b-1 marketing fee of 0.75% a year. This is general information, not personalized advice.
What does MSSLX hold?
MSSLX's largest holdings are agilon health Inc (9.1%), Cloudflare Inc (8.9%), Opendoor Technologies Inc (7.4%), Aurora Innovation Inc (6.6%), IonQ Inc (5.9%). It holds 70 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MSSLX's 5-year return?
MSSLX returned −5.4% a year over the five years ending Dec 31, 2025, and +11.8% a year over ten years. Past performance does not guarantee future results.
Does MSSLX have a sales load?
No. MSSLX has no front-end sales charge.
Who manages MSSLX?
MSSLX is offered by Morgan Stanley through Morgan Stanley Institutional Fund Inc.